Weight Loss Insights
GLP-1 analogues like semaglutide and terzepatide show promise for weight loss, with users experiencing reduced cravings and feeling fuller longer. However, a concerning aspect is the equal loss of fat and muscle, raising questions about the long-term health implications of such treatments. The conversation highlights the importance of maintaining muscle mass to prevent mortality risks associated with sarcopenia.In this clip
From this podcast
Huberman Lab
Dr. Robert Lustig: How Sugar & Processed Foods Impact Your Health
Related Questions
What does Andrew Huberman say about semaglutide, also known as GLP-1, in the episode How to Lose Fat with Science-Based Tools | Huberman Lab Podcast #21 and the clip GLP-1 Insights?
What does Andrew Huberman say about semaglutide, also known as GLP-1, in the episode How to Lose Fat with Science-Based Tools | Huberman Lab Podcast #21 and the clip GLP-1 Insights?